SHAPE Trial: Skin Health and Allergy Prevention Exposure
NCT07489040 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2026-04-06
Summary
The goal of this clinical trial is to determine if a multi-component environmental package (MEP) can prevent food allergies among infants at risk of developing food allergies in early life.
Researchers will compare the multi-component environmental package to regular care to see if the MEP works to prevent food allergies. Participants will:
* Be assigned to the multi-component environmental package or regular care once their baby is born
* Complete a weekly diary
* Attend in-office visits at 4 and 12 months of age
* Complete web-based questionnaires at 4, 6, 9 and 12 months of age
Conditions
- Allergy and Immunology
Interventions
- OTHER
-
Multi-component environmental package
Participants randomized to the intervention group (MEP) will be advised to follow the following 6 recommendations: 1. Delay first bath until target of 7 days after birth and use only water for the first bath (i.e. no soap or cleanser). 2. Bathe a target of once per week. 3. Avoid bubble baths, harsh soaps and detergents (e.g. surfactants- or lye-containing agents detailed below). 4. Avoid using antimicrobial (disinfectant) wipes (e.g. "wet wipes" such as Dr. Brown's, Parent's choice, Aleva Naturals, Munchkin Arm \& Hammer, Chicco cleaning wipes) for cleaning skin outside of the perineum/anus. 5. Avoid using dishwasher with detergents or rinse-aids for washing baby feeding devices, soothers, and toys (e.g. breast pump, nursing bottles, nipples, pacifiers, teething devices, or toys). 6. Avoid exposing the skin to food, e.g. eating over top of baby, or handling baby with food residue on hands (e.g. peanut butter), or kissing baby with food residue on lips or in mouth.
- OTHER
-
standard of care
If assigned to the control group, the parents will be advised to continue their preferred routine practices.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Derek Chu, MD, PhD, FRCPC · McMaster University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 37 Weeks
- Max Age
- 42 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2028-04-01
- Completion
- 2028-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Atopy Patch Test in Normal Population : Pilot Study
NCT01156038 ·Status: COMPLETED ·Phase: PHASE1
-
Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators
NCT07400718 ·Status: COMPLETED ·Phase: NA
-
Penicillin Allergy Testing and Resensitization Rate
NCT03942731 ·Status: COMPLETED
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy
NCT06448702 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dermal Photo Allergic Skin Reaction
NCT04070755 ·Status: COMPLETED ·Phase: PHASE1
-
NI-0801 in Allergic Contact Dermatitis
NCT01244607 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques
NCT02208414 ·Status: UNKNOWN ·Phase: NA
-
Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results
NCT06872996 ·Status: RECRUITING ·Phase: NA
-
Metal Panel Allergen Patch Test Study
NCT04500834 ·Status: UNKNOWN ·Phase: PHASE3
-
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
NCT04955951 ·Status: TERMINATED
-
Inter-arm and Inter-period Reproducability of the Dermal Blood Flow Response After a Histamine Skin Prick.
NCT04396977 ·Status: COMPLETED ·Phase: NA
-
Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy
NCT01074840 ·Status: COMPLETED ·Phase: NA
-
Drug Challenges Without Prior Skin Testing
NCT03158831 ·Status: COMPLETED ·Phase: PHASE1
-
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers
NCT03625219 ·Status: COMPLETED ·Phase: NA
-
Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
NCT00104390 ·Status: COMPLETED ·Phase: PHASE1
-
Allergy Skin Patch Artificial Intelligence (AI)
NCT05339750 ·Status: COMPLETED ·Phase: NA
-
Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy
NCT04441021 ·Status: COMPLETED
-
Cutaneous and Systemic Reactions to Metal Implants
NCT02483728 ·Status: TERMINATED ·Phase: NA
-
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
NCT04624867 ·Status: UNKNOWN ·Phase: PHASE1
-
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization
NCT04248556 ·Status: COMPLETED ·Phase: NA
-
CP-481,715 Nickel Allergy Study.
NCT00141180 ·Status: COMPLETED ·Phase: PHASE1
-
Soy Processing and Food Allergy
NCT07485699 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dermal Cumulative Irritant Patch Study
NCT04064125 ·Status: COMPLETED ·Phase: PHASE1
-
Cooling Pillow for Atopic Dermatitis
NCT01132651 ·Status: COMPLETED ·Phase: NA